{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T20:00:56Z","timestamp":1778788856980,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.prp.2025.155843","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:57:38Z","timestamp":1740185858000},"page":"155843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Estrogen receptor subtypes and survival outcomes in non-small cell lung cancer"],"prefix":"10.1016","volume":"268","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9194-3220","authenticated-orcid":false,"given":"Rina","family":"Thaker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Un Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore J.","family":"Strange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina P.","family":"Sison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue Faat Raymon","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Rafay Khan","family":"Niazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Gut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagashree","family":"Seetharamu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario R.","family":"Castellanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2025.155843_bib1","unstructured":"Lung Cancer Trends Brief: Mortality. Lung Cancer Mortality - Lung Cancer Trends Brief | American Lung Association, \u3008www.lung.org\/research\/trends-in-lung-disease\/lung-cancer-trends-brief\/lung-cancer-mortality\u3009-(1). Accessed 8 Oct. 2024."},{"key":"10.1016\/j.prp.2025.155843_bib2","series-title":"Cancers","article-title":"Sex Differences in Lung Cancer","author":"May","year":"2023"},{"key":"10.1016\/j.prp.2025.155843_bib3","series-title":"International Journal of Molecular Sciences","article-title":"Estrogen, Estrogen Receptor and Lung Cancer","author":"Hsu","year":"2017"},{"key":"10.1016\/j.prp.2025.155843_bib4","series-title":"Pathology, Research and Practice","article-title":"Expression Patterns and Clinical Significance of Estrogen Receptor in Non-Small Cell Lung Cancer","author":"Castellanos","year":"2022"},{"key":"10.1016\/j.prp.2025.155843_bib5","series-title":"Translational Lung Cancer Research","article-title":"The Prevalence and Prognostic Significance of Estrogen Receptor Beta Expression in Non-Small Cell Lung Cancer","author":"Enwere","year":"2020"},{"key":"10.1016\/j.prp.2025.155843_bib6","series-title":"Journal of Thoracic Disease","article-title":"Influence of Estrogen in Non-Small Cell Lung Cancer and Its Clinical Implications","author":"Rodriguez-Lara","year":"2018"},{"key":"10.1016\/j.prp.2025.155843_bib7","series-title":"Translational Lung Cancer Research","article-title":"Prognostic Value of the Expression of Estrogen Receptor \u03b2 in Patients with Non-Small Cell Lung Cancer: A Meta-Analysis","author":"Ma","year":"2016"},{"issue":"6","key":"10.1016\/j.prp.2025.155843_bib8","first-page":"8686","article-title":"Overexpression of estrogen receptor beta is a prognostic marker in non-small cell lung cancer: a meta-analysis","volume":"8","author":"Meta-analysis ER\u03b2 overexpression consistently linked to poor survival in NSCLC","year":"2015","journal-title":"Int J. Clin. Exp. Med"},{"issue":"3","key":"10.1016\/j.prp.2025.155843_bib9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/03936155221105521","article-title":"ERbeta overexpression may not be a direct prognostic factor in patients with NSCLC: A meta-analysis","volume":"37","author":"Li","year":"2022","journal-title":"Int J. Biol. Markers"},{"key":"10.1016\/j.prp.2025.155843_bib10","series-title":"Biomarker Research","article-title":"The Role of Estrogen Receptor Beta in Breast Cancer","author":"Zhou","year":"2020"},{"key":"10.1016\/j.prp.2025.155843_bib11","article-title":"ER Predicts Poor Prognosis in Male Lung Squamous Cell Cancer of Stage IIIA-N2 Disease after Sequential Adjuvant Chemoradiotherapy","author":"Yang","year":"2023","journal-title":"Front. Oncol., Front."},{"key":"10.1016\/j.prp.2025.155843_bib12","series-title":"Anticancer Research","article-title":"Expression of Estrogen Receptor-\u03b1 and Survival in Advanced-Stage Non-Small Cell Lung Cancer","author":"Lund-Iversen","year":"2018"},{"key":"10.1016\/j.prp.2025.155843_bib13","series-title":"Oncology Letters","article-title":"Cytoplasmic Expression of Estrogen Receptor \u03b2 May Predict Poor Outcome of EGFR-Tki Therapy in Metastatic Lung Adenocarcinoma","author":"Ding","year":"2018"},{"key":"10.1016\/j.prp.2025.155843_bib14","series-title":"Oncotarget","article-title":"Hormonal Receptors in Lung Adenocarcinoma: Expression and Difference in Outcome by Sex","author":"Berardi","year":"2016"},{"key":"10.1016\/j.prp.2025.155843_bib15","series-title":"American Journal of Translational Research","article-title":"Prognostic Significance of Aromatase and Estrogen Receptor Beta Expression in EGFR Wild-Type Lung Adenocarcinoma","author":"Tanaka","year":"2016"},{"key":"10.1016\/j.prp.2025.155843_bib16","series-title":"Oncotarget","article-title":"Nuclear Estrogen Receptor-\u03b1 Expression Is an Independent Predictor of Recurrence in Male Patients with pT1aN0 Lung Adenocarcinomas, and Correlates with Regulatory T-Cell Infiltration","author":"Kadota","year":"2015"},{"key":"10.1016\/j.prp.2025.155843_bib17","series-title":"BioMed Research International","article-title":"Potential Therapeutic Benefit of Combining Gefitinib and Tamoxifen for Treating Advanced Lung Adenocarcinoma","author":"Liu","year":"2015"},{"key":"10.1016\/j.prp.2025.155843_bib18","series-title":"Hormones & Cancer","article-title":"Differential Role of Estrogen Receptor Beta in Early versus Metastatic Non-Small Cell Lung Cancer","author":"Navaratnam","year":"2012"},{"key":"10.1016\/j.prp.2025.155843_bib19","series-title":"World Journal of Surgical Oncology","article-title":"Membrane-Bound Estrogen Receptor-\u03b1 Expression and Epidermal Growth Factor Receptor Mutation Are Associated with a Poor Prognosis in Lung Adenocarcinoma Patients","author":"Shimizu","year":"2012"},{"key":"10.1016\/j.prp.2025.155843_bib20","series-title":"Lung Cancer","article-title":"Expression Levels of Estrogen Receptor Beta in Conjunction with Aromatase Predict Survival in Non-Small Cell Lung Cancer","author":"Mah","year":"2011"},{"key":"10.1016\/j.prp.2025.155843_bib21","series-title":"An Official Journal of the American Association for Cancer Research","article-title":"Combined Analysis of Estrogen Receptor Beta-1 and Progesterone Receptor Expression Identifies Lung Cancer Patients with Poor Outcome. Clinical Cancer Research","author":"Stabile","year":"2010"},{"key":"10.1016\/j.prp.2025.155843_bib22","series-title":"Oncology Reports","article-title":"Estrogen Receptor \u03b2 and Epidermal Growth Factor Receptor as Early-Stage Prognostic Biomarkers of Non-Small Cell Lung Cancer","author":"Mauro","year":"2010"},{"key":"10.1016\/j.prp.2025.155843_bib23","series-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology","article-title":"Association between Estrogen Receptor-Beta Expression and Epidermal Growth Factor Receptor Mutation in the Postoperative Prognosis of Adenocarcinoma of the Lung","author":"Nose","year":"2008"},{"key":"10.1016\/j.prp.2025.155843_bib24","series-title":"Lung Cancer","article-title":"Oestrogen Receptor Beta over Expression in Males with Non-Small Cell Lung Cancer Is Associated with Better Survival","author":"Skov","year":"2007"},{"key":"10.1016\/j.prp.2025.155843_bib25","series-title":"American Association for Cancer Research","article-title":"Estrogen Receptor \u03b1 and \u03b2 Are Prognostic Factors in Non\u2013Small Cell Lung Cancer","author":"Kawai","year":"2005"},{"key":"10.1016\/j.prp.2025.155843_bib26","series-title":"The Journal of Thoracic and Cardiovascular Surgery","article-title":"The Significance of Estrogen Receptor Beta in 301 Surgically Treated Non-Small Cell Lung Cancers","author":"Wu","year":"2005"},{"key":"10.1016\/j.prp.2025.155843_bib27","series-title":"Clinical Cancer Research: An Official Journal of the American Association for Cancer Research","article-title":"Nuclear Estrogen Receptor Beta in Lung Cancer: Expression and Survival Differences by Sex","author":"Schwartz","year":"2005"},{"key":"10.1016\/j.prp.2025.155843_bib28","series-title":"Anticancer Research","article-title":"Combined Overexpression of EGFR and Estrogen Receptor Alpha Correlates with a Poor Outcome in Lung Cancer","author":"Kawai","year":"2005"},{"issue":"8","key":"10.1016\/j.prp.2025.155843_bib29","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/cncr.35128","article-title":"Lung cancer statistics, 2023","volume":"130","author":"Kratzer","year":"2024","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.prp.2025.155843_bib30","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41571-021-00501-4","article-title":"Evolution of systemic therapy for stages I\u2013III non-metastatic non-small- cell lung cancer","volume":"18","author":"Chaft","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.prp.2025.155843_bib31","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41571-021-00501-4","article-title":"Evolution of systemic therapy for stages I\u2013III non-metastatic non-small- cell lung cancer","volume":"18","author":"Chaft","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.prp.2025.155843_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurox.2024.100293","article-title":"Correlation between estrogen receptor and programmed death ligand-1 in type I endometrial cancer","volume":"21","author":"Waluyo","year":"2024","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol. X"},{"issue":"7","key":"10.1016\/j.prp.2025.155843_bib33","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.7150\/jca.41943","article-title":"Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Markers in Endometrial Cancer","volume":"11","author":"Wang","year":"2020","journal-title":"J. Cancer"},{"issue":"23","key":"10.1016\/j.prp.2025.155843_bib34","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa2302312","article-title":"Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer","volume":"388","author":"Eskander","year":"2023","journal-title":"N. Engl. J. Med"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825000354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825000354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T07:22:19Z","timestamp":1741159339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033825000354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":34,"alternative-id":["S0344033825000354"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2025.155843","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estrogen receptor subtypes and survival outcomes in non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2025.155843","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155843"}}